Dysbiosis News and Research

RSS

Dysbiosis is a condition caused by an imbalance in the bacterial community (microbiome) of the human gut. Dysbiosis disrupts the ecoystsem of the gut, resulting in symptoms such as diarrhea, constipation, bloating, and indigestion, among others.

Inflammation in the gut and brain may exacerbate symptoms linked with opioid withdrawal

Opioid dependence has become a national crisis with serious impact on economic and social welfare, and numerous casualties.

29 Aug 2019

Whole body vibration helps reduce inflammation, thanks to the gut microbiome

Whole body vibration appears to improve many symptoms of type II diabetes mellitus, wherein glucose and destructive inflammation shoots up. The procedure helps the body use glucose as an energy source, and at the same time, modify the microbiome to fight inflammation, a new study says.

6 Aug 2019

Company expands development plans for drugs which slow progression to dialysis

Kibow Biotech announces that the focus on supporting and maintaining healthy kidney function with probiotics/prebiotics to potentially delay the progression to dialysis is based on its enteric toxin reduction platform technology termed "Enteric Dialysis®"

From Kibow Biotech Inc. 2 Aug 2019

Scientists develop 3D printed pill that samples bacteria found in the gut

The gut microbiome is made up of trillions of living microbes, and more than a thousand species of bacteria. It has been known that the gut plays major roles in the body’s health. A team of university engineers may have developed a way to study and collect samples of microbes living in the gut.

25 Jul 2019

Harnessing the power of skin microbiome to develop new therapeutics

As scientific researchers continue to investigate the complexities of the skin microbiome, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic, dermatological & cosmetic researchers, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics).

From The Microbiome Movement 19 Jun 2019

Warning issued by FDA after patient dies following fecal transplant

A warning from the U.S FDA was issued yesterday after a patient died due to receiving a fecal transplant that contained drug-resistant bacteria.

14 Jun 2019

Chemicals produced by gut microbiome could help identify children at risk of organ failure

Chemicals produced by healthy bacteria could be used to assess the health of the gut microbiome and help identify critically-ill children at greatest risk of organ failure, a study published in Critical Care Medicine has found.

14 Jun 2019

Unhealthy gut microbiome may make breast cancers more aggressive finds study

A new study from the researchers at the University of Virginia Cancer Center connects an unhealthy gut microbiome with breast cancer that can become invasive and spread to other organs faster. The results of the study were published in the latest issue of the journal Cancer Research.

10 Jun 2019

Low vitamin D associated with potentially harmful vaginal bacteria in pregnant black women

Vitamin D, sometimes known as the sunshine vitamin, has long been known to be important for a healthy pregnancy. Pregnant mothers take vitamin D supplements to ensure their own health and that of their unborn child.

29 May 2019

Over-fed bacteria in the gut promote disease development

Since the end of the Second World War, along with the growing prosperity and the associated changes in lifestyle, numerous new and civilisation-related disease patterns have developed in today's industrialised nations.

16 May 2019

Gut bacteria and pregnancy

Researchers from Bar-Ilan University have found that with pregnancy there is a change in the composition of gut bacteria in women. This could be associated with the changing hormonal status they speculate. The results of their study titled, “Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy,” were published in the latest issue of the journal Cell Reports.

17 Apr 2019

Luxia Scientific partners with Life Genomics to commercialize microbiome-based tests in the Nordic countries

Luxia Scientific, a French biotech dedicated to improving wellbeing and health for all through the analysis and understanding of the microbiome, announced today that it has signed an exclusive distribution agreement with Life Genomics to commercialize « 1test1TM » in Nordic countries.

From Luxia Scientific 25 Mar 2019

Anti-TB drugs can increase susceptibility to Mtb reinfection

Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.

22 Mar 2019

Microbes on the tongue could be used to diagnose pancreatic cancer

Researchers have found that disruption in the microbial composition of the tongue coating could serve as a biomarker for early-stage pancreatic cancer.

31 Jan 2019

Metagenomic analysis helps understand role of bacterial species in Crohn's disease

Research on gut metagenome of patients with Crohn's disease elucidates how it influences the taxonomic and functional composition of intestinal microbiota.

31 Jan 2019

Higher vitamin C intake crucial for metabolic syndrome patients to halt cycle of antioxidant disruption

A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.

2 Jan 2019

New bacterial species may help fight obesity and metabolic disorders

The MyNewGut project has discovered new bacterial species and strains in healthy people that seem to be effective against obesity, metabolic and mental disorders related to stress and obesity (e.g. depression).

17 Dec 2018

Live probiotics can change existing gut flora and alter immune response

New research published in the International Journal of Pharmaceutics demonstrates that 'good' bacteria in the live probiotic SymproveTM can successfully reach and colonize the gut, where they go on to change the existing gut flora. They are also capable of modifying immune response.

20 Nov 2018

Immunity connects gut microbiota and age-related pathologies

EPFL scientists have discovered how a dysfunction in the immune system can cause an overload of a gut bacterium. The bacterium produces excess lactic acid, which in turn triggers the production of reactive oxygen species that cause damage to cells and many age-related pathologies.

13 Nov 2018

Study uncovers link between gut disruption and aging

A new study has shed light on how the disruption of commensal bacteria within the gut can affect the immune system and lead to age-related pathologies.

13 Nov 2018